New Brunswick-based Pivotal Health Sciences (Pivotal) is a biotechnology company with disruptive proprietary clean technologies for the extraction, encapsulation and formulation of bioactive compounds.
Operating out of Moncton, NB, Pivotal’s two patent pending technologies extract bioactives from any plant, fungi and marine source and selectively encapsulates compounds for the food, nutraceutical, cosmetics and agro-chemical sectors. Additionally, Pivotal’s sustainable green process technology will increase the effectiveness and absorption of high-value molecules for human and animal health without the addition of chemical emulsifiers, surfactants and carrier oils.
Pivotal is the latest company to join Emergence, a bioscience incubator that accelerates the growth of Atlantic Canadian startups and early-stage companies moving from ideation to commercialization. Emergence will be helping Pivotal to develop their North American regulatory and intellectual property strategy and assisting the experienced Pivotal team with protocol design for their future studies.
“The Emergence incubator, its mentors and the partner organizations that support member companies have been foundational to Pivotal’s rapid growth during our first year of operation,” said Craig Jackson, CEO, Pivotal Health Sciences. “Our organization is grateful for the opportunity to continue to receive guidance and support that will continue to accelerate our technology and products towards commercialization.”
As a client of Emergence, Pivotal will have access to business incubation services including mentorship and advisory services, team mentorship program as well as access to networks and resources.
For more information on Emergence, visit emergencebioincubator.com.